image

The best stocks to buy since 1993

Our latest issue will be released in 4 days, don't miss out!

T Clarke

February 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CTO
  • Price:
  • 142.5p
Ahead of reporting on 8 March, TClarke has seen good momentum in its core markets, with significant opportunities in data centres, healthcare, and energy efficient smart building solutions. This has led to a step up in the order book to £555m, paving the way for achieving sales of £500m in 2023. For FY22, it anticipates reporting sales up £100m to c.£425m and pretax profit up 32% to £10.3m (eps 19.3p). Forecast for this year is £10.5m pretax profit / eps 18.9p, reflecting a higher interest charge as although it ended the year with £7.5m net cash, the lumpiness of work can often shift it to a net debt position through the year and the forecasts allow for some cost headwinds. Strong hold. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe